1. Sarkar F.H., Li Y. Significance of indole-3-carbinol and its metabolites in human cancers // Evid-Based Integrative Med. 2004. N. 1. P. 33–41.
2. Aggarwal B.B., Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives // Cell Cycle. 2005. Vol. 4. N. 9. P. 1201–1215.
3. Rogan E.G. The natural chemopreventive compound indole-3-carbinol: state of the science // In Vivo. 2006. N. 20. P. 221–228.
4. Weng J.R., Tsai C.H., Kulp S.K., Chen C.S. Indole-3-carbinol as a chemopreventive and anti-cancer agent // Cancer Lett. 2008. Vol. 262. N. 2. P. 153.
5. Bradlow H.L. Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer // In Vivo. 2008. Vol. 22. N. 4. P. 441–445.
6. Ho J.N., Jun W., Choue R., Lee J. I3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cells // Mol. Med. Rep. 2013. Vol. 7. N. 2. P. 384–388.
7. Maruthanila V.L., Poornima J., Mirunalini S. Attenuation of carcinogenesis and the mechanism underlying by the influence of indole-3-carbinol and its metabolite 3,3′-diindolylmethane: a therapeutic marvel // Adv. Pharmacol. Sci. 2014. Vol. 2014. P. 832161.
8. Fares F. The anti-carcinogenic effect of indole-3-carbinol and 3,3'-diindolylmethane and their mechanism of action // Med. Chem. 2014. P. S1.
9. Popolo A., Pinto A., Daglia M. et al. Two likely targets for the anti-cancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signalling pathway and the aryl hydrocarbon receptor // Semin. Cancer Biol. 2017. N. 46. P. 132–137.
10. Kim J.K., Park S.U. Current results on the biological and pharmacological activities of indole-3-carbinol // EXCLI J. 2018. N. 17. P. 181–185.
11. Маммология. Национальное руководство / Под ред. А.Д. Каприна, Н.И. Рожковой. М.: ГЭОТАР-Медиа, 2016. С. 23–64, 311-329.
12. Мастопатии / Под ред. А.Д. Каприна, Н.И. Рожковой. М.: ГЭОТАР-Медиа, 2019. C. 51–92, 222–252.
13. https://roag-portal.ru/recommendations_gynecology.